112 related articles for article (PubMed ID: 26375454)
1. Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function.
Millen SH; Watanabe M; Komatsu E; Yamaguchi F; Nagasawa Y; Suzuki E; Monaco H; Weiss AA
PLoS One; 2015; 10(9):e0137379. PubMed ID: 26375454
[TBL] [Abstract][Full Text] [Related]
2. Genetic exchange of the S2 and S3 subunits in pertussis toxin.
Raze D; Veithen A; Sato H; Antoine R; Menozzi FD; Locht C
Mol Microbiol; 2006 Jun; 60(5):1241-50. PubMed ID: 16689799
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variation of Bordetella pertussis in Austria.
Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody that neutralizes pertussis toxin activities.
Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines].
Zawadka M; Rabczenko D; Lutyńska A
Med Dosw Mikrobiol; 2014; 66(3-4):185-94. PubMed ID: 25804072
[TBL] [Abstract][Full Text] [Related]
6. Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit.
Kamachi K; Arakawa Y
Vaccine; 2007 Jan; 25(6):1000-6. PubMed ID: 17050047
[TBL] [Abstract][Full Text] [Related]
7. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.
Ausar SF; Zhu S; Duprez J; Cohen M; Bertrand T; Steier V; Wilson DJ; Li S; Sheung A; Brookes RH; Pedyczak A; Rak A; Andrew James D
Commun Biol; 2020 Aug; 3(1):427. PubMed ID: 32759959
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7.
Sutherland JN; Maynard JA
Biochemistry; 2009 Dec; 48(50):11982-93. PubMed ID: 19899804
[TBL] [Abstract][Full Text] [Related]
9. Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis.
Lam C; Octavia S; Bahrame Z; Sintchenko V; Gilbert GL; Lan R
Infect Genet Evol; 2012 Mar; 12(2):492-5. PubMed ID: 22293463
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.
Schneider OD; Weiss AA; Miller WE
J Immunol; 2009 May; 182(9):5730-9. PubMed ID: 19380820
[TBL] [Abstract][Full Text] [Related]
11. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
12. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.
Schneider OD; Weiss AA; Miller WE
Infect Immun; 2007 Aug; 75(8):4040-9. PubMed ID: 17562776
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.
Schmidt MA; Schmidt W
Infect Immun; 1989 Dec; 57(12):3828-33. PubMed ID: 2478479
[TBL] [Abstract][Full Text] [Related]
14. Comparison of real-time PCR and pyrosequencing for typing Bordetella pertussis toxin subunit 1 variants.
Storm M; Advani A; Pettersson M; Hallander HO; Bondeson K
J Microbiol Methods; 2006 Apr; 65(1):153-8. PubMed ID: 16095736
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.
van Gent M; Heuvelman CJ; van der Heide HG; Hallander HO; Advani A; Guiso N; Wirsing von Kőnig CH; Vestrheim DF; Dalby T; Fry NK; Pierard D; Detemmerman L; Zavadilova J; Fabianova K; Logan C; Habington A; Byrne M; Lutyńska A; Mosiej E; Pelaz C; Gröndahl-Yli-Hannuksela K; Barkoff AM; Mertsola J; Economopoulou A; He Q; Mooi FR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):821-30. PubMed ID: 25527446
[TBL] [Abstract][Full Text] [Related]
16. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
17. Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.
Kamachi K; Arakawa Y
Infect Immun; 2004 Jul; 72(7):4293-6. PubMed ID: 15213178
[TBL] [Abstract][Full Text] [Related]
18. Genomics of Bordetella pertussis toxins.
Antoine R; Raze D; Locht C
Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902
[TBL] [Abstract][Full Text] [Related]
19. The ins and outs of pertussis toxin.
Locht C; Coutte L; Mielcarek N
FEBS J; 2011 Dec; 278(23):4668-82. PubMed ID: 21740523
[TBL] [Abstract][Full Text] [Related]
20. Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the ptl transport apparatus.
Burns DL; Fiddner S; Cheung AM; Verma A
Infect Immun; 2004 Sep; 72(9):5365-72. PubMed ID: 15322034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
